Oscar's record first half and raised guidance drive gains, but cost and policy risks linger
Record first-half profit and raised 2026 outlook Oscar reported record first-half earnings and lifted its full-year operating profit target by $250 million to $500–$700 million. That tells investors the core business is more profitable than expected, which supports a higher stock price.
This is the main new event that changed the company's profit outlook and directly pushes the stock up.
Second-half loss implied and cost worries The raised full-year guidance still implies a second-half operating loss of roughly $393–$593 million. Analysts also flagged rising outpatient costs and possible enrollment losses from CMS eligibility checks, which could pressure future profits and the stock.
This is the key counterweight that explains why the stock fell after the guidance hike and why future gains are not guaranteed.
Membership surges 46% despite weaker ACA market Oscar ended the second quarter with 2.96 million members, up 46% from a year earlier, even as overall ACA enrollment weakened after enhanced subsidies expired. That suggests Oscar is taking market share, which can drive future revenue and profit.
This is a new update on membership growth, a core driver of Oscar's revenue and long-term value.
Analysts lift estimates but see limited upside After the strong first half, analysts raised earnings estimates and pointed to a low PEG ratio of 0.6. However, some fair-value estimates sit below the current price, and risks remain from subsidy shifts and rising medical costs, so the stock's path depends on sustained margin improvement.
This shows how the market is repricing Oscar after the results, balancing optimism with valuation and policy risks.